Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

References 5

1. 1.

   Armitage P., Gehan E. A. Statistical methods for the identification and use of prognostic factors. Int J Cancer. 1974;13(1):16-36.

   Not in our library10.1002/ijc.2910130104

2. 2.

   Heyn R. M., Joo P., Karon M., Nesbit M., Shore N., Breslow N., Weiner J., Reed A., Hammond D. BCG in the treatment of acute lymphocytic leukemia. Blood. 1975;46(3):431-442.

   Not in our library

3. 3.

   Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50(3):163-170.

   Not in our library

4. 4.

   Mathé G., Amiel J. L., Schwarzenberg L., Schneider M., Cattan A., Schlumberger J. R., Hayat M., De Vassal F. Active immunotherapy for acute lymphoblastic leukaemia. Lancet. 1969;1(7597):697-699.

   Not in our library10.1016/s0140-6736(69)92648-8

5. 5.

   Peto R., Pike M. C. Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics. 1973;29(3):579-584.

   Not in our library

Cited by papers we hold 27

• Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials · 2022
  Corrected
• Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1) · 2020
  No notice
• The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial · 2019
  Not checked
• Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group · 2019
  No notice
• An Introduction to Survival Statistics: Kaplan-Meier Analysis · 2016
  No notice
• Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer · 2015
  Not checked
• Lung carcinogenicity of inhaled multi-walled carbon nanotube in rats · 2015
  No notice
• Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial · 2013
  No notice
• CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial · 2012
  No notice
• Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies · 2012
  No notice
• Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies · 2012
  No notice
• PIK3CAmutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups · 2012
  No notice
• The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial · 2010
  No notice
• Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target. · 2009
  Not checked
• Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype · 2009
  No notice
• Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer · 2007
  No notice
• Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study · 2006
  No notice
• Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer · 2005
  No notice
• The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481] · 2005
  No notice
• Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? · 2004
  No notice

and 7 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.